PNV

POLYNOVO FPO [PNV]

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Healthcare · ASX Small Cap

$1.0200 +2.0%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 3 consecutive scansFirst seen: 2026-05-01

Get alerts when PNV triggers a new signal

Free watchlist with daily scans for 2,200+ ASX stocks

Track PNV — Free

Active Signals

Bullish Signals

MACD momentum is losing steam
Stochastic just turned bullish from a low level — early reversal sign
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Beating the Small Ords index — relative strength of 1.19, so it's outpacing the pack
Cash positive / operating cashflow positive
Low P/S ratio (4.6x)
Moderate revenue growth (+15%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Substantial holder(s) ceased (1)
Elevated short interest (8.2%)
Earnings in sharp decline (-26% QoQ)
CANSLIM A: Turned profitable
CANSLIM I: Institutional ownership (38%)
Sentiment is mixed — no strong consensus either way
Days to cover very high (22.5)
RBA hiking (-3pts)

Risk Signals

Below the 200-day average — the long-term trend is still working against it
Post-earnings drift: negative surprise (SUE -5)
Not enough chatter to gauge sentiment — defaulting to neutral
Long-term momentum is negative — down 27% over the past year
Earnings momentum has turned negative — worth checking what's behind it

Ask Scout AI about PNV

"What's driving PNV today?" "How does PNV compare to peers?" "Key risks for PNV?"

3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE PolyNovo FY26 Results Presentation Webinar Recording

NONE ASX Announcement - FY26 Full Year Results

NONE FY26 Full Year Results and Appendix 4E

LOW FY26 Full Year Results Investor Presentation

HIGH Ceasing to be a substantial holder

Recent ASX Announcements

2026-08-26	PolyNovo FY26 Results Presentation Webinar Recording
2026-08-25	FY26 Full Year Results Investor Presentation PRICE SENSITIVE
2026-08-25	ASX Announcement - FY26 Full Year Results PRICE SENSITIVE
2026-08-25	FY26 Full Year Results and Appendix 4E PRICE SENSITIVE
2026-08-23	Ceasing to be a substantial holder

Key Metrics

$690.8M

Market Cap

2.5M

Avg Volume

0.8x

Vol Ratio

$0.81 — $1.66

52-Week Range

8.2%

Short Interest

N/A

Cash Runway

8.4%

ROE

4.9%

Profit Margin

CANSLIM Analysis

	Factor	Rating	Detail
C	Current EPS	fail	EPS Growth: -26%
A	Annual Earnings	improving	CAGR: 0%
N	New Highs / Catalysts	neutral
S	Supply & Demand	neutral	Float: 89%
L	Leader vs Laggard	pass	RS: 3
I	Institutional Sponsorship	pass	Inst: 38%
M	Market Direction	neutral	Neutral